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Markets & BusinessNews Update
Reports converge for
MEMS-on-a-chip 
Two reports find that MEMS on a chip is the
coming thing.  The Business Communication
co report The Process Spectroscopy Market
predicts  expected growth from $178m in
2004 to $232m in 2009 at  an AAGR of 5.4%.  
The hot white hope in In-Stat’s report  Market
Snapshot Lab-on-a-Chip is MEMS offering the
potential   of ‘spectrometry on a chip’ for
process monitoring,  if not between 2004-
2009 , then shortly afterward.
MEMS devices, points out BCC, have
already been employed in a portable
near-infrared (NIR) system.Acousto-optic
tunable filters (AOTFs), which provide
rapid and repeatable wavelength selec-
tion without the use of moving parts, are
being produced commercially and
employed in NIR systems that sell in the
$45,000 range (considerably cheaper
than most NIR monitors).
These two trends - increased use of MEMS
and lower-cost filters for NIR are seen as
indicators that the process spectroscopy
market 10 years from now may be signifi-
cantly different, with cheaper, more
portable systems for manufacturing use.
Also important to process spectroscopy
instrument sales is the movement of man-
ufacturing industry to offshore locations.
New plants need hardware. Process spec-
tro-scopy monitors can increase sales in
overseas locations.Technology contribu-
tions to process spectroscopy have
improved productivity, but are not ade-
quate to explain or predict its growth.
The process spectroscopy equipment
industry has witnessed consolidation and
fragmentation, with merger and acquisi-
tion, and increased participation in the
market in technology development areas
from relative newcomers.
The market includes monitors in the UV
and visible portions of the spectrum, dis-
persive near-IR analysers, Fourier trans-
form instruments operating in both the
near- and mid-IR, Raman spectrometers,
and instruments providing spectral infor-
mation outside these categories.
Near-IR monitors are expected to consti-
tute the largest market segment in 2009,
with sales of $71m. This is expected
from increased sales due to the FDA
Process Analytical Technology (PAT) ini-
tiative to streamline drug manufacturing.
The highest growth rate of any instru-
ment is expected among Raman spec-
trometers,AAGR of 8% for the period.
Raman has made significant inroads into
process monitoring, in tasks for which
the technique is very well suited. Its
expected validation as a PAT technique is
also significant for growth.
The market for process instruments in
pharmaceuticals is expected to have the
highest AAGR at 9.4% to 2009. Sales fore-
cast is $45.5m in 2009, making pharma
second in value only to the chemical &
polymer industry, with $50m sales fore-
cast for 2009.Trends include the tenden-
cy for UV and visible system makers to
develop cheaper, portable versions in
response to competition from miniature
spectrometers sold into the highly frag-
mented UV and visible market. Develop-
ment of lower-cost Raman devices is
seen as well. Near-IR and Fourier instru-
ments see no significant competition
from the portables. High-end systems, in
the near-IR, dominate process markets,
but new technologies have potential to
change that situation.
With more companies developing lab-
on-a-chip products, LOAC technology
finally appears to be making its mark in
MEMS, according to an In-Stat report:
Market Snapshot: Lab-on-a-Chip.
Revenues of devices are forecast to
increase at 31.2% CAGR through 2008,
with unit shipments nearly quadrupling
over the period.
“Key applications include life science
research (genomics, pharmaco-genomics,
and proteomics) as well as point-of-care
diagnostics,” says analyst Marlene Bourne.
“The real application to keep an eye on,
is the emerging field of clinical diagnos-
tics. Here, LOAC will allow physicians to
diagnose infectious diseases, or even cer-
tain cancers, much more rapidly.”
In-Stat has also found that:
• ’Over the next five years, point-of-care
applications will dominate total unit
shipments of LOAC devices. Life 
science research will be the prime
driver behind revenue growth.
• LOAC devices have leveraged the field
of microfluidics, and cost advantages
of micromachining, allowing the cre-
ation of complex arrays of channels,
pumps, and valves, etched into plastic,
glass, and/or silicon chips.
• Less than a dozen companies shipped
lab-on-a-chip product for revenue in
2003 - split evenly between Point-of-
Care diagnostics, and on Life Science
Research as end-use markets.
An integrated injection/separation/detection 
system developed by a DARPA team on a 2.5x4cm
substrate.
